The very first monoclonal antibody approved by the U.S. FDA (Food and Drug Administration) in 1997 ushered a new era in therapeutic applications for patients. A clinical breakthrough was acknowledged in the 1990s when there was the successful development of a humanized[…]
Read MoreTreatment of diseases arose with the concept of antibodies back in the 1890s, by Emil Adolf von Behring. In the further 1960s, there were structural characteristics describers, forward marking discovery of production methods of Monoclonal Antibodies (mAbs). The first mAb, muromonab-CD3, was[…]
Read MoreWhat level of antibody affinity do you require? What will your project’s final application be? Do you have any limits in terms of time or money? If you’re deciding between hybridoma technology steps and phage display for a monoclonal antibodies production project[…]
Read MoreWhat are monoclonal antibodies (MABs)? Monoclonal antibodies are proteins produced in the laboratory that can bind to body cells, even cancer cells. There are different types of monoclonal antibodies, or MABs, designed to carry out specific functions. At the same time, a[…]
Read More